Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial With Controlled Human Malaria Infection
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiaf435 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Lauren P Jatt und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Hauptthemen laut MEDLINE: Cytokines, Malaria, Malaria Vaccines, Malaria, Falciparum. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases of the National Institutes of Health, NIAID NIH HHS.
Themen: Patientensicherheit
Abstract (Originalsprache)
Ensuring the safety and efficacy of candidate vaccines is critical. Although mechanisms underpinning protective immune responses to malaria vaccines are frequently investigated, immune responses correlating with moderate and severe adverse events (AEs) are rarely examined. Here, we leverage a malaria vaccine trial with a higher-than-expected AE rate and frequent sampling to investigate cytokine profiles associated with AEs. We found that Interleukin-6 was elevated on days in which individuals experienced moderate and severe AEs. More research on immune responses associated with AEs is warranted in order to identify biomarkers associated with systemic reactogenicity and accelerate vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
- Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington.
- Sanaria Inc., Rockville, Maryland.
- Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
- Department of Microbiology, University of Washington, Seattle, Washington.
ORCID-Profile: Lauren P Jatt, Sean C Murphy, James R Heath, James G Kublin
Förderung
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health
- NIAID NIH HHS
Zitieren
APA
Jatt, L. P., Gillespie, K. M., Van, P., Hoffman, S. L., Jackson, L. A., Murphy, S. C., Heath, J. R., & Kublin, J. G. (2026). Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial With Controlled Human Malaria Infection. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf435
Vancouver
Jatt LP, Gillespie KM, Van P, Hoffman SL, Jackson LA, Murphy SC, et al. Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial With Controlled Human Malaria Infection. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf435
BibTeX
@article{Jatt2026,
author = {Jatt, Lauren P and Gillespie, Kevin M and Van, Phuong and Hoffman, Stephen L and Jackson, Lisa A and Murphy, Sean C and Heath, James R and Kublin, James G},
title = {Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial With Controlled Human Malaria Infection},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiaf435}
}
EUVIMED